Compounds > chenodeoxycholic acid
Page last updated: 2024-08-21

chenodeoxycholic acid and End Stage Liver Disease

chenodeoxycholic acid has been researched along with End Stage Liver Disease in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (81.82)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Chascsa, DMH; Lindor, KD1
de Veer, RC; Laschtowitz, A; Schramm, C; Van der Meer, AJ1
Carey, EJ; Chascsa, D; Lindor, KD1
Alvaro, D; Canonico, PL; Carbone, M; Craxi, A; Floreani, A; Gardini, I; Gasbarrini, A; Invernizzi, P; Kruger, P; Lanati, E; Marzioni, M; Mennini, FS; Muratori, L; Ronco, V; Vespasiani Gentilucci, U1
Floreani, A; Mangini, C1
Rockey, DC1
Carey, EJ; Yokoda, RT1
Bowlus, CL; Gershwin, ME; Invernizzi, P; Lleo, A; Mousa, HS1
Gershwin, ME; Hirschfield, GM; Trivedi, PJ1
Ali, AH; Lindor, KD1
Bowlus, CL; Kenney, JT; Navarro, R; Rice, G1

Reviews

9 review(s) available for chenodeoxycholic acid and End Stage Liver Disease

ArticleYear
Emerging therapies for PBC.
    Journal of gastroenterology, 2020, Volume: 55, Issue:3

    Topics: Chenodeoxycholic Acid; Disease Progression; End Stage Liver Disease; Female; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Ursodeoxycholic Acid

2020
Diagnosis and treatment of primary biliary cholangitis.
    United European gastroenterology journal, 2020, Volume: 8, Issue:6

    Topics: Autoantigens; Autoimmune Diseases; Bezafibrate; Biomarkers; Biopsy; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; End Stage Liver Disease; Fatigue; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Off-Label Use; Prognosis; Pruritus; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid

2020
Old and new treatments for primary biliary cholangitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:4

    Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2017
Primary biliary cholangitis: Old and novel therapy.
    European journal of internal medicine, 2018, Volume: 47

    Topics: Budesonide; Chenodeoxycholic Acid; Disease Progression; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2018
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:10

    Topics: Adult; Biliary Tract; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Immunologic Factors; Life Expectancy; Prevalence; Prognosis; Treatment Outcome; Ursodeoxycholic Acid

2019
Advances in pharmacotherapy for primary biliary cirrhosis.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:5

    Topics: Autoimmune Diseases; Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; End Stage Liver Disease; Female; Fibric Acids; Humans; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Failure; Ursodeoxycholic Acid

2015
Obeticholic acid for the treatment of primary biliary cirrhosis.
    Expert review of clinical pharmacology, 2016, Volume: 9, Issue:1

    Topics: Animals; Chenodeoxycholic Acid; Dose-Response Relationship, Drug; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Pruritus; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid

2016
Obeticholic acid for the treatment of primary biliary cholangitis.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13

    Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid

2016
Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
    Journal of managed care & specialty pharmacy, 2016, Volume: 22, Issue:10-a-s Sup

    Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Congresses as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Education, Pharmacy, Continuing; End Stage Liver Disease; Evidence-Based Medicine; Formularies as Topic; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Liver Transplantation; Middle Aged; Prescription Fees; Rare Diseases; Receptors, Cytoplasmic and Nuclear; Satellite Communications; Ursodeoxycholic Acid

2016

Other Studies

2 other study(ies) available for chenodeoxycholic acid and End Stage Liver Disease

ArticleYear
Primary Biliary Cholangitis: advances in management and treatment of the disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:8

    Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Humans; Ursodeoxycholic Acid

2017
Editorial: Advances in Hepatology: 2019.
    Current opinion in gastroenterology, 2019, Volume: 35, Issue:3

    Topics: Antiviral Agents; Blood Coagulation Disorders; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; End Stage Liver Disease; Gastroenterology; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Non-alcoholic Fatty Liver Disease; Palliative Care

2019